- Home
- BDX
as 11-25-2025 3:37pm EST
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 55.1B | IPO Year: | 1962 |
| Target Price: | $210.50 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.82 | EPS Growth: | -0.68 |
| 52 Week Low/High: | $162.29 - $251.99 | Next Earning Date: | 11-06-2025 |
| Revenue: | $21,840,000,000 | Revenue Growth: | 8.24% |
| Revenue Growth (this year): | 5.42% | Revenue Growth (next year): | 4.40% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SCOTT BERTRAM L | BDX | Director | Nov 7 '25 | Sell | $176.58 | 217 | $38,317.86 | 35,816 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Oct 27 '25 | Sell | $186.01 | 57 | $10,602.57 | 8,245 | |
| Feld Michael | BDX | EVP & President, Life Sciences | Sep 26 '25 | Sell | $181.03 | 58 | $10,499.74 | 8,245 | |
| Fraser Claire | BDX | Director | Sep 10 '25 | Sell | $187.50 | 917 | $171,937.50 | 22,226 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Becton Dickinson (NYSE:BDX) Has Announced That It Will Be Increasing Its Dividend To $1.05
Zacks
2 days ago
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
PR Newswire
2 days ago
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
MT Newswires
2 days ago
Waters Proposed Acquisition of Becton, Dickinson's Biosciences, Diagnostic Operations Gets EC's Approval
Simply Wall St.
3 days ago
How Does Becton Dickinson Stack Up After Regulatory News and Recent Price Swings?
Simply Wall St.
3 days ago
How the Story Behind BD Is Evolving After Analyst Downgrades and New Developments
Zacks
5 days ago
Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?
Insider Monkey
7 days ago
What Makes Becton Dickinson (BDX) a Good Long-Term Investment?
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.